Roctavian
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Roctavian, covering 2023-11-28 to 2026-01-14. Get the full timeline:
Most recent: EMA Authorised: Roctavian (valoctocogene roxaparvovec) — BioMarin International Limited